Clinical Trial Update: Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC [Phase 2]

View source ↗

Summary

Phase 2 trial at Oslo University Hospital investigates metformin as a means to alter tumor oxygenation and overcome radiotherapy resistance in locally advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Oslo University Hospital | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED